Melinta Urges FDA To Not Approve Minocin Generic After FedEx Debacle

Drug maker Melinta is again asking that FDA not approve a generic version of the company’s injectable antibiotic after claiming in a pair of citizen petitions and a lawsuit that the generic developer, Nexus Pharmaceuticals, failed to provide Melinta with sufficient notice that it was seeking approval. Melinta’s request is set against the backdrop of its pending patent lawsuit against Nexus in the District Court for Northern Illinois with a trial date slated for June. An FDA spokesperson declined to...